Ideas & Insights

The IRS provided long-awaited guidance for taxpayers anxious to take advantage of the NOL provisions in the CARES Act.

Recent guidance provides that certain deadlines, including the allowable time to invest in a QOF, are now extended because of COVID-19.

The IRS issued guidance extending the time for taxpayers to file certain Form 3115s and Form 1128s to July 15, 2020.

As businesses renegotiate debts in the aftermath of COVID-19, it is critical to understand whether the debt is considered publicly traded.

Accelerating worthless stock deductions on an insolvent subsidiary without disposing of the business to increase NOL carrybacks.

Delaware notices advise companies to either participate in the state’s unclaimed property VDA Program or be subject to an audit.

Proper evaluation can help life sciences companies prevent the undue state tax exposures when launching a new drug.

Emerging technology and life sciences companies can apply for a refundable tax credit for their qualifying investments.

Get yourself up to speed on the latest trends in private equity and M&A with the 2019 annual HC and LS Industry Spotlight.

Department issued compliance alert explains the sales and use tax collection responsibilities for marketplace facilitators and sellers.

Three states have prescriptions for opioid taxes on manufacturers and distributors. Here’s what you need to know.

RSM implemented the ERP system and managed the integration of the finance and accounting outsourcing technology stack.

A white paper about how entities in the life sciences industry may be affected by the new revenue recognition guidance in ASC 606.

Notwithstanding unfavorable changes to the Code, capital gain treatment is still available on the sale of patents in certain scenarios.

From contract research organizations to initial public offerings, life sciences finance leaders discuss issues in the bioscience businesses.

RSM senior industry analyst Adam Lohr shares the latest on deals, going public and more in the biotech, pharma and medical devices sectors.

What’s the secret to successful supply chain outsourcing in your life sciences business? Learn how technology can make the difference.

Syneos Health, a public company, shares its ASC 842 implementation journey and how RSM assisted with acting as an extension of their team.

Get yourself up to speed on the latest trends in private equity and mergers and acquisitions with the Q3 2019 HC and LS Industry Spotlight.

Pharmaceutical, biotech and medical device company finance leaders discuss ASC 842 lease accounting adoption complexities and challenges.